ArticleJournal of human hypertension2026
The association between APOA1 levels and long-term outcomes in H-type hypertension with acute myocardial infarction patients: A retrospective cohort study.
Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
H-type hypertension, characterized by concomitant hypertension and hyperhomocysteinemia (HHcy), is associated with heightened cardiovascular risk. Despite emerging evidence implicating apolipoprotein A1 (APOA1) in atherosclerotic processes, its prognostic value in acute myocardial infarction (AMI) patients with H-type hypertension remains underexplored.We conducted multivariable-adjusted cox regression analyses to investigate major adverse cardiovascular events (MACES) associations. Non-linear relationships were explored using restricted cubic spline (RCS) and threshold effect analyses. Survival disparities were quantified through Kaplan-Meier estimates. Stratification analyses were used to demonstrate the stability of the relationship between APOA1 and MACES. A total of 581 participants were included, with a median follow-up time of 34.00 ± 1.21 months, and 134 MACES occurred, with higher tertiles of the APOA1 associated with a lower cumulative risk of MACEs (log-rank, P < 0.001). After adjusting for confounders, the fully adjusted HRs (95% CI) for Q3 and Q4 of the APOA1, with the lowest tertile as reference, were 0.46 (0.23,0.92) and 0.42 (0.19,0.93), respectively. RCS analysis showed that APOA1 had a linear relationship with MACES. Subgroup analyses and interaction tests revealed that the association between APOA1 and MACES was negative association at most subgroup (Pinteraction >0.05). However, with the negative association observed in participants with hs-CRP > 3(mg/L), but not in those with hs-CRP ≤ 3(mg/L). In conclusion,emerging evidence demonstrates an inverse association between APOA1 and MACES risk in H-type hypertension with AMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.